1182. Risk Factors for the Acquisition of IMP-Type Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae in Japan: A Matched Case–control Study. (26th November 2018)
- Record Type:
- Journal Article
- Title:
- 1182. Risk Factors for the Acquisition of IMP-Type Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae in Japan: A Matched Case–control Study. (26th November 2018)
- Main Title:
- 1182. Risk Factors for the Acquisition of IMP-Type Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae in Japan: A Matched Case–control Study
- Authors:
- Saito, Sho
Hayakawa, Kayoko
Ishikane, Masahiro
Tajima, Taichi
Matsunaga, Nobuaki
Ide, Satoshi
Kinoshita, Noriko
Kusama, Yoshiki
Fujitomo, Yumiko
Nakamoto, Takato
Toda, Yuta
Ohmagari, Norio - Abstract:
- Abstract: Background: The majority of CRE in Japan are IMP-type carbapenemase-producing CRE (IMP-CRE). However, research on risk factors for the acquisition of IMP-CRE has been limited, and questions exist regarding whether IMP-CRE have risk factors similar to other types of CRE such as KPC. Methods: We conducted a matched case–control study involving patients from whom IMP-CRE had been isolated. The controls were selected among patients with carbapenem susceptible Enterobacteriaceae (CSE). Non-meropenem-susceptible per CLSI criteria and/or ceftazidime-resistant Enterobacteriaceae were screened, and metallo-β-lactamase–positive isolates were examined for bla IMP by PCR (January 2012 to December 2016). Results: Ninety-six patients with CRE were matched with 96 patients with CSE. They comprised Enterobacter sp. ( n = 132 [CRE: 66, CSE: 66], 68.8%) and Klebsiella pneumoniae ( n = 60 [CRE:30, CSE:30], 31.2%), and bacteria were most commonly isolated from sputum ( n = 76 [39.6%]), followed by urine ( n = 62 [32.3%]). Background factors such as age (median = 75 [IQR: 66–84]), sex (male = 56.8%), and the Charlson comorbidity index (median = 2 [IQR: 1–3.8]) were similar between CRE and CSE. In multivariate analysis, independent risk factors were identified: history of gastrointestinal (GI) endoscopy or surgery, history of ICU stay, and a previous exposure within 1 month to penicillins with β-lactamase inhibitors, cephalosporines, or carbapabnems. Conclusion: Histories of GIAbstract: Background: The majority of CRE in Japan are IMP-type carbapenemase-producing CRE (IMP-CRE). However, research on risk factors for the acquisition of IMP-CRE has been limited, and questions exist regarding whether IMP-CRE have risk factors similar to other types of CRE such as KPC. Methods: We conducted a matched case–control study involving patients from whom IMP-CRE had been isolated. The controls were selected among patients with carbapenem susceptible Enterobacteriaceae (CSE). Non-meropenem-susceptible per CLSI criteria and/or ceftazidime-resistant Enterobacteriaceae were screened, and metallo-β-lactamase–positive isolates were examined for bla IMP by PCR (January 2012 to December 2016). Results: Ninety-six patients with CRE were matched with 96 patients with CSE. They comprised Enterobacter sp. ( n = 132 [CRE: 66, CSE: 66], 68.8%) and Klebsiella pneumoniae ( n = 60 [CRE:30, CSE:30], 31.2%), and bacteria were most commonly isolated from sputum ( n = 76 [39.6%]), followed by urine ( n = 62 [32.3%]). Background factors such as age (median = 75 [IQR: 66–84]), sex (male = 56.8%), and the Charlson comorbidity index (median = 2 [IQR: 1–3.8]) were similar between CRE and CSE. In multivariate analysis, independent risk factors were identified: history of gastrointestinal (GI) endoscopy or surgery, history of ICU stay, and a previous exposure within 1 month to penicillins with β-lactamase inhibitors, cephalosporines, or carbapabnems. Conclusion: Histories of GI endoscopy and ICU stay as well as broad-spectrum antimicrobial exposure were identified as risk factors for CRE isolation. Infection control measures combined with enhanced antimicrobial stewardship are key to preventing the spread of IMP-CRE. Disclosures: All authors: No reported disclosures. … (more)
- Is Part Of:
- Open forum infectious diseases. Volume 5(2018)Supplement 1
- Journal:
- Open forum infectious diseases
- Issue:
- Volume 5(2018)Supplement 1
- Issue Display:
- Volume 5, Issue 1 (2018)
- Year:
- 2018
- Volume:
- 5
- Issue:
- 1
- Issue Sort Value:
- 2018-0005-0001-0000
- Page Start:
- S357
- Page End:
- S357
- Publication Date:
- 2018-11-26
- Subjects:
- Communicable diseases -- Periodicals
Medical microbiology -- Periodicals
Infection -- Periodicals
616.9 - Journal URLs:
- http://ofid.oxfordjournals.org/ ↗
http://www.oxfordjournals.org/en/ ↗ - DOI:
- 10.1093/ofid/ofy210.1015 ↗
- Languages:
- English
- ISSNs:
- 2328-8957
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21890.xml